Is it possible to predict outcome in pulmonary ECMO? Analysis of pre-operative risk factors

Abstract

Serious pulmonary failure may be treated with extracorporeal membrane oxygenation (ECMO) when other treatment has failed. The aim of this study was to analyze pre-operative risk factors of early mortality in patients who underwent either veno-arterial (VA) ECMO or veno-venous (VV) ECMO for pulmonary failure. We studied a total of 26 risk factors in 72 patients with severe pulmonary insufficiency treated with ECMO. All consecutive cases treated at our institution between Sept 1990 and Aug 2007 were included. Univariate analysis and multiple logistic regression analysis were performed on 26 risk factors. The end point was early mortality (any death within 30 days of ECMO treatment). Thirty-six (50%) of the patients died within 30 days of treatment. Age, gender, body mass index(BMI)(adults), cause of pulmonary failure, pre-ECMO treatment with nitric oxide(NO), intra-aortic balloon pump(IABP), and type of ventilation did not significantly influence early mortality. Neither pre-operative blood gas results, oxygenation index or pre-operative PaO₂/FiO₂ ratio, nor mean ventilator days prior to ECMO gave any indications on early mortality. Liver function did not predict early mortality, but pre-ECMO serum creatinine levels were significantly lower in patients who survived. Treatment with ECMO in patients with severe pulmonary failure may save lives. It is, however, difficult to predict outcome when initiating ECMO. In this analysis, only pre-operative serum creatinine levels correlated with survival. None of the other parameters, including those which were used to select patients for ECMO treatment, could significantly predict the outcome.

Keywords

pulmonary ECMO risk factors

Get full access to this article

View all access options for this article.

References

1 Wagner K Risnes I Abdelnoor M Karlsen HM Svennevig JL . Is it possible to predict outcome in cardiac ECMO? Analysis of preoperative risk factors. Perfusion 2007; 22: 225–229.

2 Pedersen TH Videm V Svennevig JL . Extracorporeal membrane oxygenation using a centrifugal pump and servoregulator to prevent negative inlet pressure. Ann Thorac Surg 1997; 63: 1333–1339.

3 Registry Report of the Extracorporeal Life Support Organization. Ann Arbor, MI. Extracorporeal Life Support Organization. July 2007.

4 Henzler D Dembinski R Kopp R . Treatment of acute respiratory distress syndrome in a treatment center. Success is dependent on risk factors. Anaesthesist 2004; 53: 235–243.

5 Bensberg R Dembinski R Kopp R Kuhlen R . Artificial lung and extracorporeal gas exchange. Panminerva Med 2005; 47: 11–17.

6 Morris MC Ittenbach RF Gordinez RI . Risk factor for mortality in 137 pediatric cardiac intensive care unit patients managed with extracorporeal membrane oxygenarion. Crit Care Med 2004; 32: 1061–1069.

7 Hemmila MR Rowe SA Boules TN . Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg 2004; 240: 595–607.

8 Fliman PJ deRegnier RA Kinsella JP Reynolds M Rankin LL Steinhorn RH . Neonatal extracorporeal life support: impact of new therapies on survival. J Pediatr 2006; 148: 595–599.

9 Fowler AA Hamman RF Zerbe GO Benson KH Hyers TM . Adult respiratory distress syndrome. Prognosis after onset. Am Rev Respir Dis 1985; 132: 472–478.

10.

10 Ware LB . Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design. Crit Care Med 2005; 33(3 Suppl): S217–S222.

11.

11 Lewis DA Gauger P Delosh TN Dechert RE Hirschl RB . The effect of pre ECLS ventilation on survival and respiratory morbidity in the neonatal population. J Pediatric Surg 1996; 31: 1110–1115.